Hrt Financial LP Sesen Bio, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.49 - $0.61 $15,867 - $19,753	32,382 New	32,382 $19,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.89 $60,846 - $142,508	160,122 New	160,122 $129,000
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $518,684 - $909,474	-710,527 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $547,105 - $3.49 Million	710,527 New	710,527 $563,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $826,841 - $1.77 Million	-379,285 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $493,070 - $1.23 Million	379,285 New	379,285 $986,000
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.87 $10,736 - $17,962	-20,647 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.39 - $1.03 $8,052 - $21,266	20,647 New	20,647 $11,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.